FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

ICE accuses Dem lawmaker of joining ‘rioting crowd’ in Arizona, interfering in mass arrest

Trump rips Indiana GOP leader over redistricting fight, warns Republicans could face ‘MAGA primary’

Trump administration establishes militarized zone in California: “Strengthen border security operations”

Trump admin weighs terrorism sanctions against UN Palestinian aid agency over Hamas allegations

Ukrainian woman charged over Russian-backed cyberattacks; $10M reward offered for others

Walz urges Noem to ‘reassess’ immigration enforcement strategy in Minnesota after alleged citizen arrests

Obama surprises Chicago students in Santa hat for holiday library storytime reading session

Activist group hits federal judge with judicial misconduct complaint for attending Trump rally

Elite College Football Program Rocked, Head Coach Fired in Salacious Scandal

Former music teacher allegedly groomed and had inappropriate relationship with teen student

Democrat Notches Party’s First Win in Decades in Major Red State Mayor’s Race

Multiple Suspects Arrested After 7 Students Overdose at a Single College Party

Microsoft Announces $17.5 Billion Investment in India After Laying Off Thousands of Americans in 2025

Charity Group Begs Trump for a ‘Christmas Miracle’ After USPS Rejects Hundreds of Care Packages Meant for Overseas Troops

Watch: Trump Drives a Stake Through the Heart of Fake News That He’s Ticked at Hegseth and Noem

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”